eNauka - pregled
Pregled prema Autor Havrdova, Eva
Prikaz rezultata 1 do 14 od 14
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2012 | Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial | Coles, Alasdair J; Twyman, Cary L; Arnold, Douglas L; Cohen, Jeffrey A; Confavreux, Christian; Fox, Edward J; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W; Weiner, Howard L;
Miller, Tamara; Fisher, Elizabeth; Sandbrink, Rupert; Lake, Stephen L; Margolin, David H; Oyuela, Pedro; Panzara, Michael A; Compston, D Alastair S;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2016 | Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients | Giovannoni, Gavin; Cohen, Jeffrey A.; Coles, Alasdair J.; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W.; Margolin, David H.; Lake, Stephen L.; Kaup, Susan M.; Panzara, Michael A.;
Compston, D. Alastair S.;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2012 | Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial | Cohen, Jeffrey A; Coles, Alasdair J; Arnold, Douglas L; Confavreux, Christian; Fox, Edward J; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W; Weiner, Howard L; Fisher, Elizabeth;
Brinar, Vesna V; Giovannoni, Gavin; Stojanovic, Miroslav; Ertik, Bella I; Lake, Stephen L; Margolin, David H; Panzara, Michael A; Compston, D Alastair S;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2008 | Cerebrospinal fluid cell phenotypic analysis from a phase 2 trial of the BHT-3009 DNA vaccine for multiple sclerosis | Nadj, Congor G; Nadj, Ilinka; Havrdova, Eva; Krasulova, Eva; Selmaj, Krzysztof; Losy, Jacek; Radue, Ernst-Wilhelm; Gianettoni, Jill; Solvason, Nanette; Tersini, Karen;
Valone, Frank; Utz, Paul J; Robinson, William H; Steinman, Lawrence; Garren, Hideki;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2012 | Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study | Arnold, Douglas L; Brinar, Vesna; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Fisher, Elizabeth; Fox, Edward; Giovannoni, Gavin; Hartung, Hans; Havrdova, Eva;
Selmaj, Krzysztof; Weiner, Howard; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2015 | Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study | Miller, David H.; Fox, Robert J.; Phillips, J. Theodore; Hutchinson, Michael; Havrdova, Eva; Kita, Mariko; Wheeler-Kingshott, Claudia A.M.; Tozer, Daniel J.; MacManus, David G.; Yousry, Tarek A.;
Goodsell, Mary; Yang, Minhua; Zhang, Ray; Viglietta, Vissia; Dawson, Katherine T.;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2012 | Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients | Coles, Alasdair; Brinar, Vesna; Arnold, Douglas L; Cohen, Jeffrey; Confavreux, Christian; Fox, Edward; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof; Weiner, Howard;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2012 | Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I) | Havrdova, Eva; Arnold, Douglas L; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Fox, Edward; Hartung, Hans; Selmaj, Krzysztof; Weiner, Howard; Brinar, Vesna;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Oyuela, Pedro; Panzara, Michael; Compston, Alastair;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2018 | Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome | Matute-Blanch, Clara; Villar, Luisa M.; Álvarez-Cermeño, José C.; Rejdak, Konrad; Evdoshenko, Evgeniy; Makshakov, Gleb; Nazarov, Vladimir; Lapin, Sergey; Midaglia, Luciana; Vidal-Jordana, Angela;
Drulović, Jelena
 ; García-Merino, Antonio; Sánchez-López, Antonio J.; Havrdova, Eva; Saiz, Albert; Llufriu, Sara; Alvarez-Lafuente, Roberto; Schroeder, Ina; Zettl, Uwe K.; Galimberti, Daniela; Ramió-Torrentà, Lluís; Robles, René; Quintana, Ester; Hegen, Harald; Deisenhammer, Florian; Río, Jordi; Tintoré, Mar; Sánchez, Alex; Montalban, Xavier; Comabella, Manuel; | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2008 | Phase 2 follow-up results of the BHT-3009 DNA vaccine for multiple sclerosis | Havrdova, Eva; Krasulova, Eva; Nadj, Congor G; Selmaj, Krzysztof; Losy, Jacek; Nadj, Ilinka; Radue, Ernst-Wilhelm; Gianettoni, Jill; Valone, Frank; Utz, Paul J;
Robinson, William H; Steinman, Lawrence; Garren, Hideki;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2008 | Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis | Garren, Hideki; Robinson, William H; Krasulova, Eva; Havrdova, Eva; Nadj, Congor G; Selmaj, Krzysztof; Losy, Jacek; Nadj, Ilinka; Radue, Ernst-Wilhelm; Kidd, Brian A;
Gianettoni, Jill; Tersini, Karen; Utz, Paul J; Valone, Frank; Steinman, Lawrence;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2007 | Phase IIb trial of a MBP encoding DNA plasmid (BHT-3009) for the treatment of relapsing-remitting multiple sclerosis | Garren, Hideki; Krasulova, Eva; Havrdova, Eva; Nadj, Congor G; Nadj, Ilinka; Selmaj, Krzysztof; Radue, Ernst-Wilhelm; Gianettoni, Jill; Tersini, Karen; Valone, Frank;
Robinson, William H; Utz, Paul J; Steinman, Lawrence;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2012 | Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints | Fox, Edward; Arnold, Douglas L; Brinar, Vesna; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Giovannoni, Gavin; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof;
Stojanovic, Miroslav; Weiner, Howard; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2014 | Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study | Sorensen, Per S.; Lisby, Steen; Grove, Richard; Derosier, Frederick; Shackelford, Steve; Havrdova, Eva; Drulović, Jelena ; Filippi, Massimo | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |